European Commission unveils the EU-US Privacy Shield

Life Sciences & Healthcare Update & Alert

Life Sciences & Healthcare Update & Alert

Patents Court grants declaration to Actavis in pemetrexed dispute

The Patents Court has granted Actavis a declaration in relation to its new pemetrexed product in its dispute with Eli Lilly.

Penalty clauses revisited - Supreme Court strikes light blow for freedom of contract

The Supreme Court has set out a new test for the assessment of whether a provision in an agreement should be struck down as a penalty clause

11 November 2015
类别: 

Patents Court grants interim injunction against dealings in full label generic pregabalin

The Patents Court has granted an interim injunction in respect of dealings in full label generic pregabalin products.

Patents Court finds inhaler capsule patent invalid

The Patents Court has decided that a patent relating to capsules used in a dry powder inhaler is invalid.

Patents Court: patent for immunotherapy treatment valid

The Patents Court has rejected a validity attack against a patent relating to immunotherapy treatment for cancer.

A Unitary SPC… and a recalibration?

The Commission confirms it is considering introduction of a Unitary SPC and consider recalibration of the SPC regime.

HMRC consults on changes to the Patent Box

HMRC issues consultation on revisions to the Patent Box regime.

Patents Court refuses to stay infringement proceedings relating to e-cigarettes

The Patents Court has refused to stay infringement proceedings relating to e-cigarettes pending an opposition before the EPO.

Teva secures interim injunction against Actavis in relation to rasagiline tartrate product

The Patents Court has granted an interim injunction to Teva in a patent infringement action.

Relevant date for calculating SPC term is date of notification of authorisation

Court of Justice clarified relevant date of first authorisation for purposes of calculating length of SPC.

Pregabalin: Patents Court calls for new system to deal with second medical use patents

The Patents Court has found Pfizer’s second medical use patent relating to pregabalin invalid on the grounds of insufficiency.

Court of Appeal overturns finding of invalidity on psoriasis ointment patents

The Court of Appeal has overturned Birss J’s finding of invalidity in relation to psoriasis ointment patents.

本网站使用Cookie来增强您的体验并帮助我们改善网站。请参阅我们的隐私政策以获取更多信息。如果您继续浏览网站而不更改设置,我们将假设您愿意收到这些Cookie。您可以随时更改Cookie设置

有关我们使用哪些类型Cookie的更多信息,请参阅我们的Cookie使用政策